Everyone is Encouraged to Get Their Third Vaccine

Community NewsNews
399

Translate to Spanish or other 102 languages!

Texas Border Business/Mega Doctor News Image
Texas Border Business/Mega Doctor News Image

Mega Doctor News

- Advertisement -

Today, Roberto Hugo Gonzalez, Publisher of Texas Border Business and Mega Doctor News, received his Moderna booster shot. This is the third vaccine in a series which aids in the prevention of COVID-19. He encourages everyone to get their booster shot as soon as possible. Whether you have received Moderna or Pfizer, they are readily available and always at no cost.  

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
“Turn It Off” to Help Mental Health
Next article
COVID-19 boosters offered to anyone ages 18 and older

More Articles

Robotic Surgery Program Expanded at STHS McAllen

From smaller incisions and less pain to shorter hospital stays and faster recovery times, robotic-assisted surgery is changing the way patients experience surgical care.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

Highway Crash Leads to Unexpected STC Connection

What began as a flat tire on the side of a highway turned into a frightening collision and an unexpected encounter for South Texas College faculty member Jesus Amaya, when the paramedic who responded to the scene turned out to be one of STC’s graduates.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.
- Advertisement -